Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

2.0%

1 terminated/withdrawn out of 49 trials

Success Rate

98.0%

+11.5% vs industry average

Late-Stage Pipeline

67%

33 trials in Phase 3/4

Results Transparency

50%

24 of 48 completed trials have results

Key Signals

24 with results

Enrollment Performance

Analytics

Phase 3
20(40.8%)
Phase 2
14(28.6%)
Phase 4
13(26.5%)
Phase 1
2(4.1%)
49Total
Phase 3(20)
Phase 2(14)
Phase 4(13)
Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (49)

Showing 20 of 49 trials
NCT05890001Phase 3Completed

A Study to Evaluate the Long-Term Safety of BLI5100 in Patients With Gastroesophageal Reflux Disease

Role: lead

NCT05587309Phase 3Completed

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis

Role: lead

NCT05587322Phase 3Completed

A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease

Role: lead

NCT01501513Phase 3Completed

A Safety Study of 3 Different Bowel Cleansing Preparations

Role: lead

NCT03103581Phase 2Completed

BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Role: lead

NCT03023085Phase 1Completed

A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Role: lead

NCT01442363Phase 2Terminated

A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

Role: lead

NCT04446299Phase 3Completed

Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Role: lead

NCT02822508Phase 2Completed

A Safety and Efficacy Evaluation of BLI801 Laxative in Adults Experiencing Non-Idiopathic Constipation

Role: lead

NCT04446312Phase 3Completed

Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Role: lead

NCT03328507Phase 2Completed

A Pilot Evaluation of BLI4900 Bowel Preparation in Adult Subjects

Role: lead

NCT04214301Phase 4Completed

An Open-Label Preference Evaluation of BLI800

Role: lead

NCT03261960Phase 3Completed

A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Role: lead

NCT03404401Phase 3Completed

A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy

Role: lead

NCT02819323Phase 3Completed

A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Role: lead

NCT02189850Phase 2Completed

Efficacy, Safety and Tolerability of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

Role: lead

NCT02819297Phase 3Completed

BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

Role: lead

NCT02481947Phase 3Completed

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

Role: lead

NCT02819310Phase 3Completed

An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults

Role: lead

NCT02665728Phase 2Completed

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adolescent Subjects

Role: lead